Skip to main content
Clinical Trials/NCT05389956
NCT05389956
Recruiting
Not Applicable

Identification of Risk Factors for Cardiovascular Disease and Cancer in Korean Population: A Prospective Cohort Study

Ulsan University Hospital1 site in 1 country510,000 target enrollmentJanuary 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
Ulsan University Hospital
Enrollment
510000
Locations
1
Primary Endpoint
Major adverse cardiovascular event (MACE)
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Cancer and cardiovascular disease are the global leading causes of death. These two disease entities are multifactorial disease that are caused by several factors. The aim of this prospective cohort study was to investigate the status of risk factors profiles and health related behavior in Korean population, and to discover novel risk factors associated with the occurrence of endpoint events.

Detailed Description

This is a single center, observational, prospective cohort study. The primary outcomes include the incidence of MACE (major adverse cardiovascular events) and the incidence of any malignancy. We plan to collect the baseline information at enrollment and the occurrence of clinical endpoint events will be followed for at least 10 years. The study will enroll 510,000 subjects aged ≥19 years who underwent a general health screening in Korea.

Registry
clinicaltrials.gov
Start Date
January 1, 2023
End Date
August 2052
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sangwoo Park

MD

Ulsan University Hospital

Eligibility Criteria

Inclusion Criteria

  • Men or women aged 19 years and older who underwent a general health screening at the health promotion center of Ulsan University Hospital (Ulsan, Korea)
  • Subjects have to agree to participate by signing a consent

Exclusion Criteria

  • Subjects who cannot or reject to sign the consent form.

Outcomes

Primary Outcomes

Major adverse cardiovascular event (MACE)

Time Frame: 10 year

A major adverse cardiovascular event (MACE) of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke

Incidence of malignancy

Time Frame: 10 year

The occurrence of any malignancy of interest

Secondary Outcomes

  • Cardiovascular death(10 year)
  • Myocardial infarction(10 year)
  • Stroke(10 year)
  • All-cause death(10 year)
  • Cancer related mortality(10 year)

Study Sites (1)

Loading locations...

Similar Trials